Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3950
+0.0850 (3.68%)
NASDAQ· Last Trade: Sep 1st, 3:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors